Early research (Phase 1)Study completedNCT00976261
What this trial is testing
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 72